Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06872684 · ClinicalTrials.gov registry record · NA
Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)
A NA study of Aneurysm and Aneurysm, Intracranial, sponsored by Stryker Neurovascular.
- Recruiting
- Registry status
- NA
- Development phase
- 183
- Enrollment target
- 3
- Study locations
NCT06872684 is a NA study of Aneurysm and Aneurysm, Intracranial that is actively recruiting participants, run by Stryker Neurovascular. The registered enrollment target is 183 participants, below the 17,066-participant average among 6 other Aneurysm trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT06872684, a NA study of Aneurysm and Aneurysm, Intracranial, is actively recruiting participants, sponsored by Stryker Neurovascular.
- RECRUITING
- Registry status
- NA
- Development phase
- 183 participants
- Enrollment target
- 3
- Study locations
Study Summary
The objective of the Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms with Surpass Elite with GUARDian Flow Diverter (GUARD) trial is to evaluate the safety and efficacy of the Surpass Elite with Guardian Flow Diverter System (FDS) in the treatment of unruptured, wide-neck saccular or fusiform, intracranial aneurysms (IAs) located on the internal carotid artery (ICA) or its branches.
Conditions Studied
Interventions
- DEVICE Surpass Elite with Guardian Flow Diverter System
Study Locations (3)
Arizona
- Carondelet St. Joseph's Hospital - Tucson
California
- University of California Davis Health - Davis
Massachusetts
- Lahey Hospital and Medical Center - Burlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 183 participants |
| Start Date | 2025-06-20 |
| Est. Completion | 2031-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06872684
The ClinicalTrials.gov registry entry for NCT06872684 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 183 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 17,066-participant average among 6 other Aneurysm trials with a reported enrollment target (99% lower). The listed sponsor is Stryker Neurovascular, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which Surpass Elite with Guardian Flow Diverter System is the first listed.
NCT06872684 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Arizona, California, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06872684 about?
NCT06872684 is a clinical study titled "Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)". The objective of the Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms with Surpass Elite with GUARDian Flow Diverter (GUARD) trial is to evaluate the safety and efficacy of the Surpass Elite with Guardian Flow Diverter System (FDS) in the treatment of unruptured, wide-neck sac...
What is the current status of trial NCT06872684?
This trial is currently recruiting. It is a NA study. The enrollment target is 183 participants. The study started on 2025-06-20. Estimated completion is 2031-01-31.
What conditions does trial NCT06872684 study?
This clinical trial studies the following conditions: Aneurysm, Aneurysm, Intracranial.
What interventions are being tested in trial NCT06872684?
The interventions under investigation include: Surpass Elite with Guardian Flow Diverter System (DEVICE).
Who is sponsoring clinical trial NCT06872684?
This trial is sponsored by Stryker Neurovascular, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06872684 being conducted?
This trial has 3 study locations across Arizona, California, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm (SHIELD)
RECRUITING · NA
-
An Observational Study On TheAccuracy Of Whole-Body Magnetic Resonance Imaging (Wb-Mri) ScreeningTo Predict Clinically Significant Diagnoses In General Population Subjects Interested In Proactive And Advanced General Preventive Healthcare.
RECRUITING
-
Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms
RECRUITING · Phase 1
-
PANTHER Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches
RECRUITING
-
Non-Invasive Treatment of Abdominal Aortic Aneurysm Clinical Trial
COMPLETED · Phase 2
-
Doppler Flow Wires in Cerebral Angiography
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.